Cellectis (CLLS) Asset Utilization Ratio (2015 - 2026)
Cellectis (CLLS) posted quarterly Asset Utilization Ratio of 0.23 for Q1 2026, up 54.89% year-over-year from 0.15 in Q1 2025, and up 1.72% quarter-over-quarter from 0.23 in Q4 2025.
Cellectis (CLLS) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Cellectis' Asset Utilization Ratio history runs 12 years deep, the most recent figure standing at 0.23 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 54.89% year-over-year to 0.23; the TTM figure through Mar 2026 stood at 0.23 (up 54.89% YoY), while the FY2025 annual figure was 0.21, up 50.22% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.23, up from 0.23 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.24 in Q3 2025, with the low at 0.03 in Q4 2023.
- The 5-year median for Asset Utilization Ratio is 0.08 (2023), against an average of 0.11.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio slumped 66.91% in 2022, then surged 275.38% in 2025.
- Cellectis' Asset Utilization Ratio stood at 0.07 in 2022, then slumped by 52.33% to 0.03 in 2023, then surged by 273.65% to 0.13 in 2024, then jumped by 78.5% to 0.23 in 2025, then increased by 1.72% to 0.23 in 2026.
- Business Quant data shows CLLS's Asset Utilization Ratio at 0.23 in Q1 2026, 0.23 in Q4 2025, and 0.24 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | 0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | 0.18 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.14 |
| Sep 30, 2021 | 0.13 |
| Jun 30, 2021 | 0.13 |